Chemotherapy for upper gastrointestinal tumours
Data(s) |
2000
|
---|---|
Resumo |
The aim of this review is to identify current chemotherapy treatment for tumours of the oesophagus, stomach, pancreas, and liver. The role of both neoadjuvant, adjuvant, and palliative chemotherapy regimens will be discussed. This review will be of interest to oncologists in clarifying current issues regarding chemotherapy, and to physicians in other medical specialties, to increase their general understanding of benefits and drawbacks of chemotherapy in this patient group. |
Identificador | |
Publicador |
B M J Group |
Relação |
DOI:10.1136/pmj.76.896.321 Thomas, A.L., O'Byrne, K.J., & Steward, W.P. (2000) Chemotherapy for upper gastrointestinal tumours. Postgraduate Medical Journal, 76(896), pp. 321-327. |
Direitos |
Copyright 2000 B M J Group |
Fonte |
School of Biomedical Sciences; Faculty of Health; Institute of Health and Biomedical Innovation |
Palavras-Chave | #Cancer #Chemotherapy #Oesophagus #Pancreas #Stomach #anthracycline #antiinfective agent #bleomycin #cisplatin #cyproterone acetate #docetaxel #doxorubicin #epirubicin #etoposide #fluorouracil #flutamide #gemcitabine #methotrexate #mitomycin #octreotide #tamoxifen #taxane derivative #abdominal pain #anorexia #cancer adjuvant therapy #cancer chemotherapy #cancer survival #clinical trial #digestive system cancer #dose response #esophagus cancer #esophagus resection #fever #human #liver cell carcinoma #metastasis #pancreas cancer #review #stomach cancer #Carcinoma #Hepatocellular #Chemotherapy #Adjuvant #Esophageal Neoplasms #Gastrointestinal Neoplasms #Humans #Liver Neoplasms #Palliative Care #Pancreatic Neoplasms #Radiotherapy #Adjuvant #Stomach Neoplasms #Survival Rate #Treatment Outcome |
Tipo |
Journal Article |